We want to build a diverse and inclusive workplace where every one of us can be our best and true selves, so that together we can discover more, reach underserved communities and reimagine medicine. Learn more about our commitments to diversity and inclusion, embedded in our Code of Ethics.

 

Our People & Perspectives

Laurent Fred

Announcing our membership of the Valuable 500

As we mark the UN’s International Day of Persons with Disabilities, we’re delighted to announce that Novartis has joined The Valuable 500, supporting a global movement to drive systemic change and innovate together for disability inclusion.

Learn More
twighlight sky with stars dark blue image

Addressing health disparities through holistic community-based collective action

We’re working with partners to co-create programs that address the root causes of systemic disparities in health outcomes and create greater diversity, equity and inclusion across the research and development ecosystem.

Learn More
Black lives matter

Standing for Racial Equity and Justice as One Novartis

We believe unequivocally that Black Lives Matter. As a company focused on improving human health globally, we also recognize the disparities Black communities and communities of color face when it comes to healthcare.

Read More
Our new parental leave policy helps Michael to share precious moments with his family

Parental Leave

14 weeks minimum paid parental leave, countless precious moments.  Find out more about our Global Equal Parental Leave Policy for all Novartis parents.

Learn More

 


Latest News

Woman scientist in lab

Novartis included again in the 2022 Bloomberg Gender-Equality Index

We are fully committed to gender equity and inclusion at Novartis.  That’s why we are proud to announce our continued inclusion in the 2022 Bloomberg Gender-Equality Index.

Meeting in open space

Novartis top pharma company in Refinitiv Most Diverse & Inclusive Companies 2020

We are proud to be recognized in the Refinitiv Top 25 Most Diverse & Inclusive Companies 2020 as the leading pharma company for the third year in a row.

Learn More

 


D&I Governance and Community